Cover Image
市場調查報告書

心律調節器/ICD (置入式除顫器) 導線系統:醫療設備的開發平台分析

Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 361018
出版日期 內容資訊 英文 87 Pages
訂單完成後即時交付
價格
Back to Top
心律調節器/ICD (置入式除顫器) 導線系統:醫療設備的開發平台分析 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年06月06日 內容資訊: 英文 87 Pages
簡介

本報告提供全球心律調節器用及置入式除顫器 (以下簡稱ICD) 導線系統市場上主要開發中產品及其臨床實驗的進展調查,再加上產品的功能·特性比較分析 (臨床實驗的各進展階段) ,並彙整主要企業簡介及代表性產品,近來的市場動靜 (業績報告·資本交易趨勢等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 心律調節器/ICD用導線系統 (導線)的概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • 心律調節器/ICD用導線系統的企業:各臨床實驗階段的開發中產品
  • 心律調節器/ICD用導線系統:各臨床實驗階段的開發中產品

第5章 心律調節器/ICD用導線系統:企業·產品概要

  • Boston Scientific Corporation
    • 開發中產品及進行中的臨床實驗概要
  • Imricor Medical Systems, Inc.
  • LivaNova PLC
  • Mayo Clinic US
  • Medtronic plc
  • MicroPort Scientific Corporation
  • MRI Interventions, Inc
  • St. Jude Medical, Inc.
  • Teleflex Incorporated

第6章 心律調節器/ICD用導線系統:近來的市場趨勢 (全34件)

第7章 附錄

圖表一覽

目錄
Product Code: GDME0203EPD

GlobalData's Medical Devices sector report, "Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Medical Devices Pipeline Assessment, 2016" provides an overview of Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Overview

3. Products under Development

  • 3.1. Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Stage of Development
  • 3.2. Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Territory
  • 3.3. Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Regulatory Path
  • 3.4. Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Estimated Approval Date
  • 3.5. Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Ongoing Clinical Trials

4. Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products under Development by Companies

  • 4.1. Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Companies - Pipeline Products by Stage of Development
  • 4.2. Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Stage of Development

5. Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Companies and Product Overview

  • 5.1. Boston Scientific Corporation Company Overview
    • 5.1.1. Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Imricor Medical Systems, Inc. Company Overview
    • 5.2.1. Imricor Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. LivaNova PLC Company Overview
    • 5.3.1. LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Mayo Clinic US Company Overview
    • 5.4.1. Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Medtronic plc Company Overview
    • 5.5.1. Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. MicroPort Scientific Corporation Company Overview
    • 5.6.1. MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. MRI Interventions, Inc Company Overview
    • 5.7.1. MRI Interventions, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. St. Jude Medical, Inc. Company Overview
    • 5.8.1. St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Teleflex Incorporated Company Overview
    • 5.9.1. Teleflex Incorporated Pipeline Products & Ongoing Clinical Trials Overview

6. Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads- Recent Developments

  • 6.1. May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results
  • 6.2. May 04, 2016: Medtronic Welcomes Karen L. Parkhill as Its New Chief Financial Officer
  • 6.3. Apr 28, 2016: Boston Scientific Announces Scheduled Presentation on Acuity X4 Quad LV Lead At Heart Rhythm Society 2016
  • 6.4. Apr 27, 2016: Abbott Labs to Acquire St. Jude Medical for up to USD25 Billion
  • 6.5. Apr 25, 2016: Boston Scientific Receives U.S. FDA Approval For ImageReady MR-Conditional Pacing System
  • 6.6. Apr 20, 2016: BIOTRONIK ICD Lead Data from Long-Term Registries Published by Journal of Cardiovascular Electrophysiology
  • 6.7. Apr 20, 2016: St. Jude Medical Reports First Quarter 2016 Results
  • 6.8. Apr 06, 2016: Medtronic Statement on U.S. Department of Treasury's Recent Temporary and Proposed Regulations
  • 6.9. Mar 29, 2016: St. Jude Medical Announces CE Mark Approval and Launch of Expanded Selection of Quadripolar Pacing Leads
  • 6.10. Mar 17, 2016: Medtronic Proposes Proxy Access
  • 6.11. Mar 01, 2016: Medtronic Reports Third Quarter Financial Results
  • 6.12. Feb 23, 2016: Boston Scientific Receives U.S. FDA Approval For Quadripolar Leads And Initiates Global Trial To Expand MRI Labeling To The U.S. And Asia
  • 6.13. Feb 19, 2016: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2016
  • 6.14. Feb 17, 2016: St. Jude Medical Receives FDA Approval for Industry's First MultiPoint Pacing Technology
  • 6.15. Jan 27, 2016: St. Jude Medical Reports Fourth Quarter and Full-Year 2015 Results
  • 6.16. Jan 22, 2016: FDA Classifies St. Jude Medical Field Action for 447 of the Company's Optisure High Voltage Leads as a Class 1 Advisory in the U.S.
  • 6.17. Jan 13, 2016: St. Jude Medical Announces Preliminary Fourth Quarter 2015 Financial Results
  • 6.18. Jan 11, 2016: Medtronic Updates Capital Allocation Plans and Fiscal 2016 EPS Guidance
  • 6.19. Dec 14, 2015: The Medtronic Bakken Invitation Award Honors 12 Patients from Around the World for Giving Back
  • 6.20. Nov 30, 2015: Boston Scientific Retrieves Certain Lots Of 9Fr ACUITY Pro Coronary Sinus Outer Guide Catheters
  • 6.21. Nov 20, 2015: Medtronic Statement on U.S. Department of Treasury's Notice 2015-79
  • 6.22. Oct 21, 2015: St. Jude Medical Reports Third Quarter 2015 Results
  • 6.23. Sep 28, 2015: Medtronic InFuse Lawsuit May Reach Supreme Court, Parker Waichman LLP Comments
  • 6.24. Sep 14, 2015: Incoming St. Jude Medical President and CEO Mike Rousseau Announces Executive Leadership Team
  • 6.25. Sep 10, 2015: Sorin and Cyberonics Announce Appointment of LivaNova's Chief Financial Officer
  • 6.26. Sep 09, 2015: St. Jude Medical Announces Leadership Transition Plan
  • 6.27. Sep 08, 2015: No Further Legal Action By Italian State's Attorney To Enjoin The Combination Of Sorin And Cyberonics
  • 6.28. Sep 03, 2015: Medtronic Reports First Quarter Financial Results
  • 6.29. Aug 05, 2015: St. Jude Medical Appoints David Dvorak to Its Board of Directors
  • 6.30. Jul 30, 2015: Sorin Group Announces Results for the Second Quarter of 2015
  • 6.31. Jul 27, 2015: Sorin And Cyberonics Announce Intent To Vigorously Contest Claim By Italian State's Attorney Seeking To Enjoin The Proposed Combination Of The Companies
  • 6.32. Jul 22, 2015: St. Jude Medical Reports Second Quarter 2015 Results
  • 6.33. Jul 14, 2015: Malaysia, The Hub Of Medical Device Manufacturing In Asean
  • 6.34. Jun 25, 2015: Sorin And Cyberonics Unveil Name Of Combined Company: LivaNova

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Stage of Development
  • Table 2: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Territory
  • Table 3: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Regulatory Path
  • Table 4: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Estimated Approval Date
  • Table 5: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Ongoing Clinical Trials
  • Table 6: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Companies - Pipeline Products by Stage of Development
  • Table 7: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Stage of Development
  • Table 8: Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: ENDOTAK RELIANCE 4-SITE Defibrillation Lead System - Product Status
  • Table 10: ENDOTAK RELIANCE 4-SITE Defibrillation Lead System - Product Description
  • Table 11: INGEVITY Pacing Lead - Product Status
  • Table 12: INGEVITY Pacing Lead - Product Description
  • Table 13: Next Generation ICD Lead - Product Status
  • Table 14: Next Generation ICD Lead - Product Description
  • Table 15: Reliance 4-Front Lead - Product Status
  • Table 16: Reliance 4-Front Lead - Product Description
  • Table 17: X4 SYSTEM + QUAD LEAD - Product Status
  • Table 18: X4 SYSTEM + QUAD LEAD - Product Description
  • Table 19: Boston Scientific Corporation - Ongoing Clinical Trials Overview
  • Table 20: ENDOTAK RELIANCE 4-SITE Defibrillation Lead System - Longitudinal Surveillance Study of the 4-SITE Lead/Header System
  • Table 21: INGEVITY Pacing Lead - ImageReady MR Conditional Pacing System Clinical Study
  • Table 22: INGEVITY Pacing Lead - INGEVITY Active Fixation and Passive Fixation Pace/ Sense Lead Clinical Study
  • Table 23: INGEVITY Pacing Lead - INGEVITY Observational Trial: Assessment of Routine Experience and Magnet Resonance Imaging (MRI) Usage with a New Lead for Bradycardia Pacing
  • Table 24: Reliance 4-Front Lead - Evaluation of Acuity X4 Quadripolar Coronary Venous Leads and Reliance 4-Front Defibrillation Leads: NAVIGATE X4
  • Table 25: Reliance 4-Front Lead - Reliance 4-Front Active Fixation Defibrillation Lead Post Market Clinical Follow-Up (PMCF) Study
  • Table 26: Reliance 4-Front Lead - RELIANCE 4-FRONT Passive Fixation Defibrillation Lead Post Market Clinical Follow-up (PMCF) Study
  • Table 27: Imricor Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: Magnetic Resonance Imaging (MRI) Compatible Lead - Product Status
  • Table 29: Magnetic Resonance Imaging (MRI) Compatible Lead - Product Description
  • Table 30: LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: Beflex Brady Lead - Product Status
  • Table 32: Beflex Brady Lead - Product Description
  • Table 33: Nano Lead System - Product Status
  • Table 34: Nano Lead System - Product Description
  • Table 35: SonR Tist Lead Positioning - Product Status
  • Table 36: SonR Tist Lead Positioning - Product Description
  • Table 37: SonRFix Lead - Product Status
  • Table 38: SonRFix Lead - Product Description
  • Table 39: Tachy Lead - Product Status
  • Table 40: Tachy Lead - Product Description
  • Table 41: TX Brady Lead - Product Status
  • Table 42: TX Brady Lead - Product Description
  • Table 43: LivaNova PLC - Ongoing Clinical Trials Overview
  • Table 44: SonRFix Lead - SonR FIX Atrial Lead Multi-Centre Clinical Trial
  • Table 45: Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview
  • Table 46: Epicardial Pacing/sensing Lead - Product Status
  • Table 47: Epicardial Pacing/sensing Lead - Product Description
  • Table 48: Pacemaker/ICD Lead - Product Status
  • Table 49: Pacemaker/ICD Lead - Product Description
  • Table 50: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: Pacing Lead (Model 4296 LV Lead) - Product Status
  • Table 52: Pacing Lead (Model 4296 LV Lead) - Product Description
  • Table 53: Medtronic plc - Ongoing Clinical Trials Overview
  • Table 54: Pacing Lead (Model 4296 LV Lead) - Attain Ability Family Left Ventricular Lead Chronic Performance Study
  • Table 55: MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 56: Active Pacing Lead - Product Status
  • Table 57: Active Pacing Lead - Product Description
  • Table 58: Passive Pacing Lead - Product Status
  • Table 59: Passive Pacing Lead - Product Description
  • Table 60: MRI Interventions, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 61: MRI-Safe Implantable Cardiac Lead - Product Status
  • Table 62: MRI-Safe Implantable Cardiac Lead - Product Description
  • Table 63: St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 64: Quartet NXT - Double Blend Lead - Product Status
  • Table 65: Quartet NXT - Double Blend Lead - Product Description
  • Table 66: Quartet NXT - Large S-Curve Lead - Product Status
  • Table 67: Quartet NXT - Large S-Curve Lead - Product Description
  • Table 68: Quartet NXT - Small S-Curve Lead - Product Status
  • Table 69: Quartet NXT - Small S-Curve Lead - Product Description
  • Table 70: Tendril MRI lead - Product Status
  • Table 71: Tendril MRI lead - Product Description
  • Table 72: St. Jude Medical, Inc. - Ongoing Clinical Trials Overview
  • Table 73: Tendril MRI lead - A Clinical Evaluation of the SJM MRI Conditional Pacing System in Subjects Undergoing Cardiac Magnetic Resonance Imaging in India
  • Table 74: Tendril MRI lead - Accent Magnetic Resonance Imaging Pacemaker and Tendril Magnetic Resonance Imaging Lead Investigational Device Exemption Study
  • Table 75: Teleflex Incorporated Pipeline Products & Ongoing Clinical Trials Overview
  • Table 76: Pacemaker Lead - Product Status
  • Table 77: Pacemaker Lead - Product Description
  • Table 78: Glossary

List of Figures

  • Figure 1: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Stage of Development
  • Figure 2: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Territory
  • Figure 3: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Regulatory Path
  • Figure 4: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Estimated Approval Date
  • Figure 5: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Ongoing Clinical Trials
Back to Top